Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Imray

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Plos One|August 8, 2013
Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantationNithya S Krishnan, Daniel Zehnder, Sunil Daga, et al.
Transplantation Direct|July 22, 2021
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor TransplantationNithya Krishnan, Aisha Abimbola, Nandhini Machan, et al.
Transplantation|August 14, 2008
Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantationNithya S Krishnan, Paul Fleetwood, Robert M Higgins, et al.
Stroke|June 13, 2022
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II TrialTimo Uphaus, Toby Richards, Christian Weimar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
C3d-positive donor-specific antibodies have a role in pretransplant risk stratification of cross-match-positive HLA-incompatible renal transplantation: United Kingdom multicentre studyAdarsh Babu, Natasha Khovanova, Olivia Shaw, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos One|August 8, 2013
Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantationNithya S Krishnan, Daniel Zehnder, Sunil Daga, et al.
Transplantation Direct|July 22, 2021
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor TransplantationNithya Krishnan, Aisha Abimbola, Nandhini Machan, et al.
Transplantation|August 14, 2008
Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantationNithya S Krishnan, Paul Fleetwood, Robert M Higgins, et al.
Stroke|June 13, 2022
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II TrialTimo Uphaus, Toby Richards, Christian Weimar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
C3d-positive donor-specific antibodies have a role in pretransplant risk stratification of cross-match-positive HLA-incompatible renal transplantation: United Kingdom multicentre studyAdarsh Babu, Natasha Khovanova, Olivia Shaw, et al.
Pageof 2